Parametric Portfolio Associates’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-78,542
Closed -$484K 3621
2021
Q2
$484K Sell
78,542
-5,325
-6% -$39.4K ﹤0.01% 3098
2021
Q1
$614K Buy
83,867
+308
+0.4% +$2.63K ﹤0.01% 3398
2020
Q4
$679K Sell
83,559
-2,181
-3% -$16.8K ﹤0.01% 3225
2020
Q3
$677K Buy
85,740
+67,982
+383% +$464K ﹤0.01% 3123
2020
Q2
$97K Buy
+17,758
New +$88.2K ﹤0.01% 3791

Other funds holding ETON

Parametric Portfolio Associates's ETON Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Eton Pharmaceutcials (ETON) in Q3 2021, closing a stake of 78,542 shares — an estimated $484K sold.

Parametric Portfolio Associates first reported a position in ETON in Q2 2020 and held it in 5 quarters. The position peaked at $679K in Q4 2020. 37 funds tracked by Wall St. Rank hold ETON as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Eton Pharmaceutcials position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 78,542 Eton Pharmaceutcials shares in Q3 2021, an estimated $484K.
  • Parametric Portfolio Associates first reported a position in Eton Pharmaceutcials in Q2 2020 and held it in 5 quarters.
  • Parametric Portfolio Associates's Eton Pharmaceutcials position peaked at $679K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.